Zydus, ICMR initiate Phase 2 clinical trial of Desidustat in patients with Sickle Cell Disease Read more
Accord BioPharma’s Biosimilar IMULDOSA gains USFDA approval for treatment of chronic inflammatory conditions Read more
University of Central Lancashire partners with Brinton Healthcare UK to explore nanoparticle technology for skin disease treatment Read more